Bexion Pharmaceuticals
Bexion Pharmaceuticals is a mid-stage clinical company developing life-changing treatments in Oncology and CNS.
27 employees · est. 2006 · Covington, United States
LYNK Pharmaceuticals
Pioneering novel treatments for oncology, immunology, and inflammatory diseases since 2018.
11-50 employees · est. 2018
Bexion Pharmaceuticals is the older company (2006 vs 2018).
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Bexion Pharmaceuticals | LYNK Pharmaceuticals |
|---|---|---|
| Founded | ||
| Founded | 2006 older | 2018 |
| Headquarters | ||
| Headquarters | Covington, United States | Not tracked yet |
| Employees | ||
| Employees | 27 | 11-50 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Life Sciences | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Unknown | Series C |
| Total Funding | ||
| Total Funding | $18.00M | $402.00M |
| Funding Rounds | ||
| Funding Rounds | 4 | 7 |
| Services | ||
| Services | Development of cancer therapies, Clinical-stage drug development, Phase 1b/2a clinical trials, Biologic therapy research | Not tracked yet |
| Target Customers | ||
| Target Customers | Cancer patients, Oncologists, Clinical researchers, Biopharmaceutical investors | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Oncology, CNS (Central Nervous System), S1P Modulator, BXQ-350, Tumor Targeting, Phosphatidylserine Patches, Acid Sphingomyelinase Activation, Ceramide Generation, Caspase Elevation, Biopharmaceutical, Clinical Development, Novel Mechanism Of Action, Tumor Neovasculature, Apoptosis Induction | Oncology, Immunology, Inflammatory Diseases, Biotech Enterprise, Novel Treatments, Medicine Discovery, Medicine Development, Pharmaceutical Research, Innovative Medicines, Biotechnology Focus, Disease Treatment |
| Website | ||
| Website | bexionpharma.com | en.lynkpharma.com |
About Bexion Pharmaceuticals
Bexion Pharmaceuticals, founded in 2006, is a United States-based company operating at the forefront of the Biopharma, Biotechnology, Life Sciences, and Pharmaceutical industries. The company has carved out a niche in developing transformative treatments within the oncology and central nervous syste...
About LYNK Pharmaceuticals
LYNK Pharmaceuticals, established in 2018, is a promising player in the biotechnology and pharmaceutical sectors. With a focus on pioneering novel treatments for oncology, immunology, and inflammatory diseases, the company is based in Hangzhou, Zhejiang, China. Recently, LYNK Pharmaceuticals secure...
We will tell you when either one moves
BounceWatch watches Bexion Pharmaceuticals and LYNK Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Bexion Pharmaceuticals and LYNK Pharmaceuticals — by email.
Frequently Asked Questions
Compare Bexion Pharmaceuticals with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Bexion Pharmaceuticals on 11 Mar 2026, and LYNK Pharmaceuticals on 21 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
